---
schema_version: "secwatch.filing_event.v1"
accession: "0000877860-25-000028"
form_type: "8-K"
ticker: "NHI"
cik: "0000877860"
company_name: "NATIONAL HEALTH INVESTORS INC"
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T05:18:45.971037+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# NHI Q4 net income $0.95/diluted share; introduces 2025 FFO guidance $4.59-$4.66

## Summary
- Q4 2024 NAREIT FFO per diluted share $1.24 (up from $1.09 YoY); Normalized FFO $1.12 vs $1.09.
- Full-year 2024 normalized FFO $4.44 (up from $4.33 YoY); Normalized FAD $204.2M vs $187.8M.
- 2025 guidance: NAREIT/Normalized FFO per diluted share $4.59-$4.66; assumes $225M new investments at 8.1% yield.
- Closed $237.5M in acquisitions in 2024 (most active since 2019); signed LOIs for $152.3M at ~8.2% yield.
- SHOP occupancy reached 90% in Jan 2025 vs 84.4% a year ago; SLM credit loss reserve $14.8M on non-performing loans.

## SEC filing metadata
- accession: 0000877860-25-000028
- form_type: 8-K
- ticker: NHI
- cik: 0000877860
- company_name: NATIONAL HEALTH INVESTORS INC
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/877860/000087786025000028/0000877860-25-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/877860/000087786025000028/nhi-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000877860-25-000028
- JSON: https://secwatch.observer/filing/0000877860-25-000028.json
- Plain text: https://secwatch.observer/filing/0000877860-25-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.